Contineum Therapeutics (CTNM) EBT Margin (2023)
Contineum Therapeutics' EBT Margin history spans 1 years, with the latest figure at 84.6% for Q2 2023.
- Quarterly EBT Margin changed N/A to 84.6% in Q2 2023 from the year-ago period, while the trailing twelve-month figure was 63.45% through Jun 2024, changed N/A year-over-year, with the annual reading at 46.34% for FY2023, N/A changed from the prior year.
- EBT Margin came in at 84.6% for Q2 2023.
- In the past five years, EBT Margin ranged from a high of 84.6% in Q2 2023 to a low of 84.6% in Q2 2023.